DPH Share Price

Open 1264.00 Change Price %
High 1273.47 1 Day -29.00 -2.28
Low 1243.00 1 Week -47.00 -3.64
Close 1243.00 1 Month -84.00 -6.33
Volume 190451 1 Year 246.00 24.67
52 Week High 1462.00
52 Week Low 811.00
DPH Important Levels
Resistance 2 1271.25
Resistance 1 1259.61
Pivot 1253.16
Support 1 1226.39
Support 2 1214.75
LON UK Most Active Stocks
CWC 74.60 0.27%
CWC 74.60 0.27%
CWC 74.60 0.27%
INC 0.04 -20.00%
HER 0.02 0.00%
HER 0.02 0.00%
LLOY 57.55 -0.07%
VOD 191.40 0.21%
VOD 191.40 0.21%
OTC 0.03 0.00%
More..
LON UK Top Gainers Stocks
AKT 28.50 5177.78%
HHR 58.00 900.00%
MES 0.28 75.00%
MES 0.28 75.00%
MES 0.28 75.00%
PFLM 5.75 64.29%
LDP 0.03 50.00%
LDP 0.03 50.00%
AMC 13.50 25.58%
AMC 13.50 25.58%
More..
LON UK Top Losers Stocks
ENDV 0.02 -99.85%
KEA 0.10 -91.30%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
DCP 0.50 -75.61%
PCI 3.50 -53.27%
PCI 3.50 -53.27%
BHR 0.02 -33.33%
NBR 0.25 -24.24%
More..

Dechra Pharmaceuticals PLC (LON: DPH)

DPH Technical Analysis 2
As on 2nd Dec 2016 DPH Share Price closed @ 1243.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1209.81 & Strong Sell for SHORT-TERM with Stoploss of 1336.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
DPH Target for December
1st Target up-side 1344.68
2nd Target up-side 1391.41
3rd Target up-side 1438.14
1st Target down-side 1211.32
2nd Target down-side 1164.59
3rd Target down-side 1117.86
DPH Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.dechra.com
DPH Address
DPH
24 Cheshire Avenue
Cheshire Business Park
Northwich, CW9 7UA
United Kingdom
Phone: 44 1606 814 730
Fax: 44 1606 814 731
DPH Latest News
Interactive Technical Analysis Chart Dechra Pharmaceuticals PLC ( DPH LON UK )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Dechra Pharmaceuticals PLC
DPH Business Profile
Dechra Pharmaceuticals PLC is engaged in the development, manufacture, distribution, sale, and marketing of veterinary pharmaceuticals worldwide. It markets and sells licensed branded pharmaceuticals and specialist pet foods to the veterinary professionals in Europe, as well as manufactures products for third party customers. The company also markets and sells a range of endocrine, ophthalmic, dermatological, and equine products in North America. In addition, it develops and licenses its branded veterinary product portfolio of novel and generic pharmaceuticals, and specialist pet diets. The company distributes its products through a mixture of its own direct sales, wholesalers, and national distributor channels. Dechra Pharmaceuticals PLC is headquartered in Northwich, the United Kingdom.